Similar articles

• [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].

  Lacour J, Lacour F, Spira A, Michelson M, Petit JY, Delage G, Sarrazin D, Contesso G, Viguier J. Lacour J, et al. Chirurgie. 1984;110(4):418-24. Chirurgie. 1984. PMID: 6389040 Clinical Trial. French. No abstract available.
• [Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].

  Lacour F, Lacour J, Spira A, Michelson M, Petit JY, Delage G, Contesso G, Merlin-Nahon E, Sarrazin D, Viguier J. Lacour F, et al. Chirurgie. 1980 Nov;106(9):737-43. Chirurgie. 1980. PMID: 7009093 Clinical Trial. French. No abstract available.
• Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.

  Lacour J, Lacour F, Ducot B, Spira A, Michelson M, Petit JY, Sarrazin D, Contesso G. Lacour J, et al. Eur J Surg Oncol. 1988 Aug;14(4):311-6. Eur J Surg Oncol. 1988. PMID: 3044833 Clinical Trial.
• Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.

  Conrad B, Kieser R. Conrad B, et al. Arch Geschwulstforsch. 1986;56(3):211-36. Arch Geschwulstforsch. 1986. PMID: 3524501 Review.
• [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].

  Fodor J, Polgár C, Németh G. Fodor J, et al. Orv Hetil. 2000 Jul 9;141(28):1551-5. Orv Hetil. 2000. PMID: 10957865 Review. Hungarian.